Table 5.

Summary of the results of the meta-analysis of the association of APOB gene polymorphisms and hyperlipidemia

SNP	Analysis model	Genotype model	Heterogeneity(I2/P)	OR(95%CI)	P	Publication bias P
APOB MspI	A	M- vs M+	0.0%/ 0.731	0.892(0.756 ~ 1.053)	0.178	0.452
	D	M-M−/M + M- Vs M + M+	0.0%/0.716	0.868(0.716 ~ 1.053)	0.152	0.707
	R	M-M-vs M + M−/M + M+	0.0%/ 0.513	0.932(0.596 ~ 1.456)	0.757	0.908
	C	M-M- vs M + M+	0.0%/ 0.555	0.903(0.574 ~ 1.421)	0.660	0.883
		M + M- vs M + M+	0.0%/ 0.654	0.864(0.705 ~ 1.057)	0.156	0.746
APOB XbaI	A	T vs C	72.4%/ < 0.001	1.444(1.061 ~ 1.966)	0.020	0.732
	D	TT + CT vs CC	73.5%/ < 0.001	1.360(0.943 ~ 1.962)	0.100	0.945
	R	TT vs CT + CC	0.0%/ 0.747	1.613(1.022 ~ 2.545)	0.040	0.707
	C	TT vs CC	0.0%/ 0.774	1.432(0.851 ~ 2.411)	0.017	0.724
		CT vs CC	73.5%/ < 0.001	1.322(0.912 ~ 1.917)	0.140	0.837
APOB EcorI	A	A vs G	70.0%/ < 0.001	1.333(0.942 ~ 1.885)	0.104	0.474
	D	AA+AG Vs GG	72.9%/ < 0.001	1.366(0.924 ~ 2.020)	0.118	0.283
	R	AA vs AG + GG	0.0%/ 0.942	1.183(0.628 ~ 2.229)	0.603	0.221
	C	AA vs GG	0.0%/ 0.886	1.166(0.617 ~ 2.202)	0.637	0.086
		AG vs GG	72.6%/ < 0.001	1.356(0.913 ~ 2.015)	0.131	0.371

A allelic model; D dominant model; R recessive model; C codominant model; Publication bias P: using Begg’s or Egger’s tests